D-0473-2018 Class III Terminated
FDA drug recall D-0473-2018 was initiated by Nostrum Laboratories Inc on February 13, 2018 and is designated Class III. Reason for recall: Presence of Foreign Tablets/Capsules The recall status is terminated (terminated December 13, 2018). Affected quantity: 1,439,000 oral capsules.
Recall Details
- Product Type
- Drugs
- Report Date
- February 28, 2018
- Initiation Date
- February 13, 2018
- Termination Date
- December 13, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,439,000 oral capsules
Product Description
Calcium Acetate Capsules, 667 mg, 200 Capsules per bottle, Rx Only. Manufactured by Nostrum Laboratories, Inc. Kansas City, MO 64120. NDC 29033-026-02
Reason for Recall
Presence of Foreign Tablets/Capsules
Distribution Pattern
Nationwide
Code Information
Lot: CAL173502; Exp. 09/19